ProMIS Neurosciences Inc (PMN) Stock Analysis
Verdict: AVOID
Imminent liquidity exhaust and severe dilution risk overshadow early AD pipeline assets following a 70.1% single-day price collapse.
Investment score: 22/100
Analysis as of
Is ProMIS Neurosciences Inc stock worth reviewing? The TradeMates thesis
TradeMates assigns an AVOID rating to ProMIS Neurosciences (PMN) due to an unsustainable cash burn rate ($6.12M cash vs -$28.12M annual burn) and high probability of equity dilution following a 70.1% price collapse to $3.31.
7-factor investment score
- Valuation: 20/100 (weight 20%)
- Financial Health: 5/100 (weight 15%)
- Technical Momentum: 10/100 (weight 15%)
- Earnings Quality: 30/100 (weight 15%)
- Insider Sentiment: 50/100 (weight 10%)
- Analyst Consensus: 45/100 (weight 10%)
- Risk-Adjusted Return: 10/100 (weight 15%)
ProMIS Neurosciences Inc opportunities and risks
What speaks for PMN
- Selective PMN310 binding mechanism for Alzheimer's disease
What speaks against PMN
- Imminent cash runway exhaustion under 3 months
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| PMN | n/a | 0.0x | 0.6x | 0.0% | 0.0% | -141.5% |
| BCT.TO | n/a | 0.0x | n/a | 0.0% | 0.0% | -107.2% |
| MDNA.TO | n/a | 0.0x | n/a | 0.0% | 0.0% | -40.6% |
| EDSA | n/a | 0.0x | n/a | 0.0% | 0.0% | -36.2% |
| DTC.CN | n/a | 0.0x | n/a | 0.0% | 0.0% | -18.0% |
| RVX.TO | n/a | 0.0x | n/a | 0.0% | 0.0% | -22.0% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -36.2% |
Frequently asked questions about ProMIS Neurosciences Inc (PMN)
Is PMN stock a good investment?
The TradeMates model rates ProMIS Neurosciences Inc as AVOID with an investment score of 22/100. TradeMates assigns an AVOID rating to ProMIS Neurosciences (PMN) due to an unsustainable cash burn rate ($6.12M cash vs -$28.12M annual burn) and high probability of equity dilution following a 70.1% price collapse to $3.31. This is algorithmic model output, not personal investment advice.
Is PMN stock a buy?
The TradeMates model verdict for PMN is AVOID with an investment score of 22/100. Treat this as a model signal to review, not a personal buy recommendation.